HUTCHMED (China) Limited (0013.HK)

HKD 23.0

(-0.22%)

Total Assets Summary of HUTCHMED (China) Limited

  • HUTCHMED (China) Limited's latest annual total assets in 2023 was 1.27 Billion USD , up 24.32% from previous year.
  • HUTCHMED (China) Limited's latest quarterly total assets in 2024 Q1 was 1.26 Billion USD , down -1.48% from previous quarter.
  • HUTCHMED (China) Limited reported annual total assets of 1.02 Billion USD in 2022, down -25.0% from previous year.
  • HUTCHMED (China) Limited reported annual total assets of 1.37 Billion USD in 2021, up 89.56% from previous year.
  • HUTCHMED (China) Limited reported quarterly total assets of 1.26 Billion USD for 2024 Q2, down 0.0% from previous quarter.
  • HUTCHMED (China) Limited reported quarterly total assets of 1.29 Billion USD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of HUTCHMED (China) Limited (2023 - 2005)

Historical Annual Total Assets of HUTCHMED (China) Limited (2023 - 2005)

Year Total Assets Total Assets Growth
2023 1.27 Billion USD 24.32%
2022 1.02 Billion USD -25.0%
2021 1.37 Billion USD 89.56%
2020 724.11 Million USD 55.68%
2019 465.12 Million USD -12.59%
2018 532.11 Million USD -11.01%
2017 597.93 Million USD 74.61%
2016 342.43 Million USD 49.05%
2015 229.75 Million USD 4.94%
2014 218.93 Million USD 17.92%
2013 185.66 Million USD -11.36%
2012 209.46 Million USD 7.54%
2011 194.77 Million USD 21.79%
2010 159.92 Million USD 25.18%
2009 127.75 Million USD 8.31%
2008 117.95 Million USD -7.53%
2007 127.56 Million USD -4.12%
2006 133.04 Million USD 111.58%
2005 62.88 Million USD 0.0%

Peer Total Assets Comparison of HUTCHMED (China) Limited

Name Total Assets Total Assets Difference
Pak Fah Yeow International Limited 907.46 Million HKD -41.027%
Grand Pharmaceutical Group Limited 22.51 Billion HKD 94.316%
Extrawell Pharmaceutical Holdings Limited 1.28 Billion HKD 0.576%
Wai Yuen Tong Medicine Holdings Limited 2.09 Billion HKD 38.916%
Qianhai Health Holdings Limited 478.11 Million HKD -167.669%
Lee's Pharmaceutical Holdings Limited 2.89 Billion HKD 55.727%
Essex Bio-Technology Limited 2.82 Billion HKD 54.739%
Tongfang Kontafarma Holdings Limited 1.72 Billion HKD 25.911%
PuraPharm Corporation Limited 843.96 Million HKD -51.639%
SSY Group Limited 11.96 Billion HKD 89.305%
JBM (Healthcare) Limited 1.38 Billion HKD 7.844%
Jacobson Pharma Corporation Limited 3.48 Billion HKD 63.297%
China Resources Pharmaceutical Group Limited 271.69 Billion HKD 99.529%